Zydus Lifesciences said its Ankleshwar manufacturing facility received three observations from the USFDA after a recent inspection, adding that none of the findings were linked to data integrity issues.
Wellness initiatives enhance employee performance by improving health focus and engagement while fostering long-term community health through reduced disease burdens and stronger social ties.
Merck has partnered with a global health coalition to improve access to its Ebola vaccine, aiming to reduce costs and ensure availability in regions most affected by the virus. The initiative focuses on saving lives and controlling outbreaks.
Abbott has received CE Mark approval for its TactiFlex Duo Ablation Catheter in Europe, marking a major step forward in AFib treatment with dual-energy technology and successful first commercial cases.
Dentalkart partners with NSK Japan to offer authentic dental equipment in India with transparent pricing and faster after-sales support.
GSK has agreed to acquire RAPT Therapeutics for $2.2 billion, adding ozureprubart, a long-acting anti-IgE antibody, to its pipeline and strengthening its push into food allergy treatment.
Boston Scientific Corporation has signed a definitive agreement to acquire US-based medical device company Penumbra Inc. in a transaction valued at approximately $14.5 billion, strengthening its presence in vascular and neurovascular therapi...
Abbott has entered into a strategic collaboration with AtaCor Medical to develop an investigational extravascular implantable cardioverter defibrillator (EV-ICD) system, aimed at improving the safety and effectiveness of therapy for patien...
Zydus Lifesciences has received USFDA approval for its generic Eltrombopag tablets, strengthening its U.S. generics portfolio and opening access to a blood disorder drug with strong commercial potential.
Alembic Pharmaceuticals has clinched tentative approval from the US Food & Drug Administration (USFDA) for its Bosutinib Tablets, 400?mg — a major generic cancer drug move that expands its foothold in the lucrative US oncology market...
, CDSCO.jpg)